1-5 of 5
Edgar Ulises Coronado
Close
Sort by
Journal Articles

Outpatient Low-Dose Venetoclax Plus Azacitidine Vs. Intensive Chemotherapy for Newly Diagnosed Fit Patients with Acute Myeloid Leukemia in a Limited Resource Setting

Yadith Karina Lopez-Garcia, Fernando De La Garza, Gerardo Alexis De la Rosa-Flores, Edgar Ulises Coronado Alejandro, Antonio Vega-Mateos, Ana Cristina Tejada Vasquez, Gerardo Garcia-Salas, Valeria García-Zárate, Perla R. Rocio Colunga-Pedraza, David Gomez-Almaguer, Andres Gomez-De Leon
Journal: Blood
Blood (2023) 142 (Supplement 1): 1529.
https://doi.org/10.1182/blood-2023-188088
Published: 2023
Journal Articles

Lost and Found: A Mixed Methods Study on Treatment Abandonment in Acute Leukemia

Ana Cristina Tejada Vasquez, Eliezer Gomez, Fernando De La Garza, Edgar Ulises Coronado Alejandro, Carlos De La Cruz-De La Cruz, Valeria García-Zárate, Anna Cecilia Rodriguez-Zuñiga, Alexia Sánchez, David Gomez-Almaguer, Andres Gomez-De Leon
Journal: Blood
Blood (2023) 142 (Supplement 1): 2439.
https://doi.org/10.1182/blood-2023-189645
Published: 2023
Journal Articles

Is VTD the Best First Line Therapy for Multiple Myeloma in an Environment with Limited Resources? an Analysis of Outcomes and Costs

Eliezer Tomas Tomas Gomez Gomez, David Gomez Almaguer, Cesar Homero Gutierrez-Aguirre, Perla R.R. Colunga-Pedraza, Luz Tarin-Arzaga, Jose Carlos Jaime, Edgar Ulises Coronado, Fernando De La Garza, Estefania Guadarrama Rendon, Santiago Calzada Davila
Journal: Blood
Blood (2022) 140 (Supplement 1): 7710–7711.
https://doi.org/10.1182/blood-2022-163772
Published: 2022
Journal Articles

Romiplostim, Low-Dose Rituximab and High-Dose Dexamethasone Combination in Newly Diagnosed Immune Thrombocytopenia: Another "Total Therapy" Pilot Study

Perla R. R. Colunga-Pedraza, Mónica Bustillos Muñoz, Fernando De La Garza, Andres Gomez-De Leon, Edgar Ulises Coronado-Alejandro, Eliezer Tomas Gomez Gomez, Ana Varela-Constantino, Gerardo A De la rosa-Flores, Olga Graciela Cantu Rodriguez, Cesar Homero Gutierrez-Aguirre, Luz del Carmen Tarín Arzaga, David Gomez-Almaguer
Journal: Blood
Blood (2021) 138 (Supplement 1): 1014.
https://doi.org/10.1182/blood-2021-149769
Published: 2021
Journal Articles

Low-Dose Nivolumab Plus Brentuximab Vedotin As a Bridge to Stem Cell Transplantation in Relapsed/Refractory Classical Hodgkin Lymphoma

Perla R. R. Colunga-Pedraza, Edgar Ulises Coronado-Alejandro, Fernando De La Garza, Eliezer Tomas Gomez Gomez, Andres Gomez-De Leon, Julia Esther Colunga Pedraza, Cesar Homero Gutierrez-Aguirre, Olga Graciela Cantu Rodriguez, David Gomez-Almaguer
Journal: Blood
Blood (2021) 138 (Supplement 1): 4534.
https://doi.org/10.1182/blood-2021-153267
Published: 2021